Medication info

Amapi LM Tablets 2/500 mg

Prescription medicationTabletOral
Ingredient · strength
Glimepiride›2mg / 1 tabletMetformin Hydrochloride›500mg / 1 tablet
Manufacturer / importer
Young Poong Pharmaceutical Co., Ltd.
Appearance
White oblong film-coated tablet
Packaging
30 tablets/bottle - 30 tablets/bottle[30 tablets/bottle], 100 tablets/bottle - 100 tablets/bottle[100 tablets/bottle]
Approval status
Active

MFDS item code 201603388 · Approved 2016.06.13

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
Administer this medicine 1~2 times daily immediately before or with meals. The dose may be adjusted based on each patient's current treatment regimen, efficacy, and tolerability; appropriate blood glucose monitoring should be performed for this purpose. Treatment is generally initiated at a low dose, which may be adjusted based on the patient's current medications and blood glucose levels. In clinical trials, the initial daily dose was glimepiride/metformin hydrochloride 2 mg/500 mg, and there is experience with gradual dose increases, guided by blood glucose monitoring results, up to glimepiride/metformin hydrochloride 8 mg/2000 mg. For glimepiride monotherapy, there is generally little additional benefit at doses above 4 mg daily, although some patients achieved better metabolic control when the dose was increased to 6 mg (or 8 mg). When used as a replacement for combination therapy, administer according to the dosage and administration regimen of the glimepiride and metformin hydrochloride currently being taken in combination. Even if a previous dose was missed, do not take more than a single dose at the next scheduled administration.

Ingredients

Manufacturer
Young Poong Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

View approved original text

This medication is used to improve blood sugar control in patients with type 2 diabetes, complementing dietary and exercise therapy.

How to take

Adult dose

Administer this medicine 1~2 times daily immediately before or with meals. The dose may be adjusted based on each patient's current treatment regimen, efficacy, and tolerability; appropriate blood glucose monitoring should be performed for this purpose. Treatment is generally initiated at a low dose, which may be adjusted based on the patient's current medications and blood glucose levels. In clinical trials, the initial daily dose was glimepiride/metformin hydrochloride 2 mg/500 mg, and there is experience with gradual dose increases, guided by blood glucose monitoring results, up to glimepiride/metformin hydrochloride 8 mg/2000 mg. For glimepiride monotherapy, there is generally little additional benefit at doses above 4 mg daily, although some patients achieved better metabolic control when the dose was increased to 6 mg (or 8 mg). When used as a replacement for combination therapy, administer according to the dosage and administration regimen of the glimepiride and metformin hydrochloride currently being taken in combination. Even if a previous dose was missed, do not take more than a single dose at the next scheduled administration.

Precautions

This medication may cause severe lactic acidosis or hypoglycemia, and should be discontinued if kidney function declines sharply. It is advisable to temporarily stop taking this medication and consult a physician if dehydration occurs due to diarrhea, vomiting, or fever. Care should be taken when using this medication in patients with impaired kidney function or those taking medications that may affect the kidneys. Patients with cardiovascular disease should discuss cardiovascular risks with their doctor before and after taking this medication. This medication should not be used in patients with insulin-dependent diabetes, acute metabolic acidosis, severe liver dysfunction, pregnant or breastfeeding women, or those with severe kidney impairment. As this medication can cause hypoglycemia, especially patients with poor nutritional status or irregular eating habits, the elderly, and those with liver dysfunction should be carefully observed for hypoglycemic symptoms. Gastrointestinal disturbances (diarrhea, nausea, vomiting, etc.) may occur at the beginning of treatment, but are usually temporary and can be alleviated by taking it with meals. If allergic reactions, skin rashes, or breathing difficulties occur, inform a doctor immediately. This medication may reduce vitamin B12 levels, so it is recommended to have regular vitamin B12 tests during long-term use. There may be interactions with other medications, so it is essential to consult healthcare professionals when starting or stopping new medications. Do not use this medication during pregnancy or breastfeeding; instead, insulin therapy should be considered if necessary. In children or the elderly, regular kidney function tests are necessary, and dose adjustments may be required. In case of overdose, hypoglycemia or lactic acidosis may occur, so inform healthcare professionals immediately and receive appropriate treatment. When driving or operating machinery, caution is advised due to the risk of accidents from hypoglycemia or dizziness. This medication should be stored out of reach of children, and care should be taken not to transfer it to other containers.

Side effects

Lactic acidosis, hypoglycemia, diarrhea, nausea, vomiting, abdominal bloating, loss of appetite, dyspepsia, constipation, abdominal pain, malaise, metallic taste, visual impairment, taste disorder, allergic reactions (erythema, itching, urticaria, rash), thrombocytopenia, leukopenia, hemolytic anemia, erythrocytopenia, granulocytopenia, agranulocytosis, pancytopenia, vitamin B12 deficiency, peripheral neuropathy, increase in liver enzymes, liver function impairment, cholestasis, jaundice, hepatitis, allergic vasculitis, photosensitivity, decreased serum sodium concentration, hypothyroidism, magnesium deficiency in case of diarrhea, encephalopathy, hair loss, weight gain, clinical symptoms of hypoglycemia (headache, severe hunger, nausea, vomiting, fatigue, sleepiness, weakness, drowsiness, sleep disturbances, instability, aggression, attention deficit, inability to focus, abnormal reactions, depression, confusion, speech disorders, aphasia, visual disturbances, tremors, paralysis, sensory disturbances, dizziness, inability to self-regulate, delirium, cerebral seizures, loss of consciousness, coma, weak breathing, slow pulse, sweating, clammy skin, anxiety, rapid pulse, hypertension, palpitations, angina, deep vein thrombosis)

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air or moisture from entering. It is best to store it at room temperature between 1 to 30 degrees Celsius. Proper storage will help maintain the medication's effectiveness over time.

Appearance and packaging

Appearance

White oblong film-coated tablet

Package unit

30 tablets/bottle - 30 tablets/bottle[30 tablets/bottle], 100 tablets/bottle - 100 tablets/bottle[100 tablets/bottle]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.